Dr. Gellad joined the faculty of the University of Pittsburgh in 2008. His research focuses on physician prescribing practices and on policy issues affecting access to medications for patients. He is the recipient of a VA Health Services Research and Development (HSR&D) Career Development Award to address regional variation in drug prescribing and spending among patients with diabetes in the VA system. He is currently studying the role of formulary management within the VA in affecting high-cost drug use, as well as the relationship between prescribing in the VA and Medicare/Medicaid. He is also working with colleagues at the University of Pittsburgh to study the diffusion of new medications in public insurance programs. Dr. Gellad is also a nationally recognized authority on medication adherence, having authored several reviews on the barriers to medication adherence for patients.
In addition to his research, Dr. Gellad is a board-certified practicing internist. He is a former member of the FDA Advisory Committee on Nonprescription Drugs and an alternate member of the FDA Drug Safety Oversight Board. Prior to joining the University of Pittsburgh faculty, Dr. Gellad was an instructor of Medicine at Harvard Medical School and Brigham and Women's Hospital, where he completed his residency and chief residency in internal medicine and a health services research training fellowship. He received his undergraduate degree from Swarthmore College, his medical degree summa cum laude from the University of Maryland, and a master's degree in public health from Harvard.